Home/Filings/4/0001048477-24-000090
4//SEC Filing

Hubbard Cristin 4

Accession 0001048477-24-000090

CIK 0001048477other

Filed

May 21, 8:00 PM ET

Accepted

May 22, 4:36 PM ET

Size

8.3 KB

Accession

0001048477-24-000090

Insider Transaction Report

Form 4
Period: 2024-05-20
Hubbard Cristin
EVP, Chief Commercial Officer
Transactions
  • Award

    Common Stock

    2024-05-20+4,70019,390 total
  • Award

    Common Stock

    2024-05-20+14,69014,690 total
  • Award

    Stock Option (Right to Buy Common Stock)

    2024-05-20+33,52033,520 total
    Exercise: $77.05From: 2025-05-20Exp: 2034-05-19Common Stock (33,520 underlying)
Footnotes (2)
  • [F1]Restricted stock units granted on May 20, 2024. Price not applicable.
  • [F2]Option grant vests 12/48th on May 20, 2025 and 1/48th on the 1st day of each month thereafter.

Issuer

BIOMARIN PHARMACEUTICAL INC

CIK 0001048477

Entity typeother

Related Parties

1
  • filerCIK 0002021836

Filing Metadata

Form type
4
Filed
May 21, 8:00 PM ET
Accepted
May 22, 4:36 PM ET
Size
8.3 KB